AN2 THERAPEUTICS INC (ANTX)
US0373261058 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -64.73M | -40.96M | -21.54M | -13.60M | -5.64M | |||
| Change In Working Capital | 5.83M | 3.72M | 30.00K | 1.22M | -10.00K | |||
| Other non cash items | 5.61M | 3.78M | 1.03M | 7.02M | 3.16M | |||
| OPERATING CASH FLOW | -53.29M | -33.46M | -20.48M | -5.36M | -2.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | -43.28M | -21.77M | -50.02M | 0.00 | N/A | |||
| INVESTING CASH FLOW | -43.28M | -21.77M | -50.02M | 0.00 | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 84.99M | 70.36M | 79.75M | 3.84M | 8.08M | |||
| Other Financing Activity | N/A | 0.00 | -1.21M | 0.00 | N/A | |||
| FINANCING CASH FLOW | 84.99M | 70.36M | 78.54M | 3.84M | 8.08M | |||
| CHANGE IN CASH | -11.57M | 15.13M | 8.04M | -1.52M | 5.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.29M | -33.46M | -20.48M | -5.36M | -2.49M | |||
| FREE CASH FLOW | -53.29M | -33.46M | -20.48M | -5.36M | -2.49M | |||
All data in USD